In December, PersonGen.Anke Cellular Therapeutics Co., Ltd. was approved as an enterprise technology center in Anhui Province

In December, PersonGen.Anke Cellular Therapeutics Co., Ltd. was awarded as a specialized and innovative small and medium-sized enterprise in Anhui Province

In December, PersonGen.Anke Cellular Therapeutics Co., Ltd. was awarded as a gazelle cultivation enterprise in Hefei High-tech Zone in 2024

In November, Wang Min, vice president of PersonGen.Anke Cellular Therapeutics Co., Ltd., was awarded the gold worker of Hefei

In November,  PersonGen BioTherapeutics (Suzhou) Co., Ltd. won the winning enterprise award in the final of the 13th China Innovation and Entrepreneurship Competition for Disruptive Technology Innovation

In November,  PersonGen BioTherapeutics (Suzhou) Co., Ltd. was awarded as an outstanding enterprise (growth group) in the 13th China Innovation and Entrepreneurship Competition

In November,  PersonGen BioTherapeutics (Suzhou) Co., Ltd. was selected as one of the top 100 Innovative Pharmaceutical Enterprises in China in 2024

In November,  PersonGen BioTherapeutics (Suzhou) Co., Ltd. won the second prize in the third Yangtze River Delta G60 Science and Technology Innovation Corridor Science and Technology and Industrial Innovation Competition "Winning the Future"

In October, Yang Lin, founder of PersonGen, was selected as an expert in the identification of high-tech enterprises and the evaluation of science and technology projects in Anhui Province

In August, Wang Min, vice president of PersonGen.Anke Cellular Therapeutics Co., Ltd.was selected as an expert in science and technology review in Anhui Province

In July, Yang Lin, founder of PersonGen, was appointed as an industry professor at the Collaborative Innovation Center of Hematology of Soochow University

In June, the results of phase I clinical study of PA3-17 injection were selected for oral presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

In May,  PersonGen BioTherapeutics (Suzhou) Co., Ltd. was awarded the CGCS Awards Rising Star Award for cell Therapy R&D

In May, PersonGen BioTherapeutics (Suzhou) Co., Ltd. was listed in the 2024 Future Medical Top 100-2024 China Innovative Medicine and Biological Products TOP100

In April, Wang Min, vice president of PersonGen.Anke Cellular Therapeutics Co., Ltd., was awarded the nomination for the fifth "Hefei High-tech Zone Youth May 4th Medal"

In April, two universal γδT cell products from PersonGen were selected for poster presentation at the 2024 American Association for Cancer Research Annual Meeting (AACR 2024)

In April,  PersonGen BioTherapeutics (Suzhou) Co., Ltd.was awarded the 2024 Best Technical Breakthrough Award by CGT Industry Star

In March, Yang Lin, founder of PersonGen, was selected as a member of Jiangsu Provincial Talent Innovation and Entrepreneurship Promotion Association

In February, PersonGen.Anke Cellular Therapeutics Co., Ltd. won the second prize of the 9th Workers' Technological Innovation Award in Hefei

In January,  PersonGen.Anke Cellular Therapeutics Co., Ltd. was awarded as an innovative small and medium-sized enterprise in Anhui Province